Breast Cancer Breakout: Rapid research developments and new treatment combinations

Breast cancer is one of the most diagnosed cancers among women, with an estimated 2.1 million new cases of breast cancer globally each year. Immunotherapy for breast cancer is developing rapidly following the first FDA-approved checkpoint inhibitor for triple-negative breast cancer in March 2019. New treatment regimens combining immunotherapy with chemotherapy, radiation, or surgery are showing promise in clinical trials. Dr. Elizabeth Mittendorf of Dana-Farber/Harvard Cancer Center will answer your questions and discuss current immunotherapy research for breast cancer.

[@Optunity]

Thank you for your efforts hard work and let’s keep cancer awareness alive and growing until cancer has a cure

[@CancerResearchInstitute]

Thanks for watching!

[@alicias312]

Happy I found this. Is it to late for questions?

[@johnc2217]

This is a beautiful video. Thank you 🙏

[@CancerResearchInstitute]

Thanks for watching, John!

[@thyda9163]

Thank you 🙏🙏🙏

[@CancerResearchInstitute]

Thanks for watching!

[@stchannel2476]

I enjoyed watching this. Thank you Doctorsx

[@CancerResearchInstitute]

Thanks for watching!